DOC-2/DAB2 interacting protein (DAB2IP) is a RasGAP protein that shows a suppressive effect on cancer progression. Our previous study showed the involvement of transcription regulation of DAB2IP in metastasis of colorectal cancer (CRC). However, the molecular mechanisms of DAB2IP in regulating the progression of CRC need to be further explored. Here, we identified heterogeneous nuclear ribonucleoprotein K (hnRNPK) and matrix metalloproteinase 2 (MMP2) as vital downstream targets of DAB2IP in CRC cells by two-dimensional fluorescence difference gel electrophoresis and cDNA microassay, respectively. Mechanistically, down-regulation of DAB2IP increased the level of hnRNPK through MAPK/ERK signaling pathway. Subsequently, translocation of hnRNPK into nucleus enhanced the transcription activity of MMP2, and therefore promoted invasion and metastasis of CRC. Down-regulation of DAB2IP correlated negatively with hnRNPK and MMP2 expressions in CRC tissues. In conclusion, our study elucidates a novel mechanism of the DAB2IP/hnRNPK/MMP2 axis in the regulation of CRC invasion and metastasis, which may be a potential therapeutic target.
Colorectal cancer (CRC) is the main reason for cancer deaths and the third most common malignancy in the world. 1 CRC survival is related to the stage of disease at diagnosis, with over 90% 5-year survival rate for cancers identified at an early stage, 70% with regional spread and <10% for patients with metastatic disease. 2, 3 Therefore, the search for highly sensitive and specific markers for CRC metastasis prediction, diagnosis and prognosis, is an important research topic for this deadly disease.
DAB2IP, a member of the RAS-GTPase activating protein (RAS-GAP) family, 4 is down-regulated in several cancer types. In prostate cancer, low expression of DAB2IP affects proliferation, survival, apoptosis and epithelial-mesenchymal transition (EMT) through several signaling pathways, including Ras-ERK, ASK-JNK, and PI3K-Akt. [5] [6] [7] Moreover, DAB2IP methylation is frequently present in prostate cancer, lung cancer, breast cancer, etc and the resulting gene silencing plays an important role in carcinogenesis. 4, 8, 9 Our previous study demonstrated that DAB2IP was significantly down-regulated in CRC tissues and the positive feedback between snail and DAB2IP regulated EMT, invasion and metastasis of CRC. 10 However, the downstream signaling pathways regulated by DAB2IP in the progression of CRC remain unclear.
In this study, we illustrate that down-regulation of DAB2IP activates MAPK/ERK signailing pathway and subsequently promotes the translocation of heterogeneous nuclear ribonucleoprotein K (hnRNPK) into nucleus to enhance the transcription activity of matrix metalloproteinase 2 (MMP2), and therefore promotes invasion and metastasis of CRC.
Materials and Methods
Cell culture CRC cell lines SW480 and HCT116 were perchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China) and maintained as previously described. 11 The cell lines were authenticated by short tandem repeat (STR) profiling before receipt and were propagated for <6 months after resuscitation. Cells were cultured in RPMI 1640 (Hyclone; Logan, Utah, USA) supplemented with 10% fetal bovine serum (Gibco-BRL, Invitrogen; Paisley, UK) in a 5% CO 2 humidified atmosphere at 378C.
Construction of plasmid and transfection
Lentiviral constructs repressing DAB2IP, repressing hnRNPK, overexpressing hnRNPK and repressing MMP2 (Genechem, Shanghai City, China) were packaged using the pPACKH1 lentivector Packaging Kit (System Biosciences, USA) and were used to infect CRC cells to establish stable cells. DAB2IP-shRNA (sense 5 0 -GGG AUA GGC UAA GGA GUAA dTdT-3 0 ). hnRNPK-shRNA (sense 5 0 -CCG GCA GTG CTG ATA TTG AGA CGA TCT CGA GAT CGT CTC AAT ATC AGC ACT GTT TTTG dTdT-3 0 ). MMP2-shRNA (sense 5 0 -GAG ACA AAU UCU GGA GAUA dTdT-3 0 ). In the rescue experiments, hnRNPK depleting cells were transfected with shRNAs towards DAB2IP and hnRNPK overexpressing cells were transfected with shRNAs towards MMP2.
Two-dimensional fluorescence difference gel electrophoresis (2 D DIGE)
The 2 D DIGE was performed as previously described. 12 The proteins were labelled with fluorescent cyanine dyes (GE Healthcare, Milwaukee, WI) following the manufacturer's instructions. In brief, 50 lg of extracted protein to be compared was labelled with 400 pmol Cy3 or Cy5, while 400 pmol Cy2 was employed to label 50 lg of internal standard protein of each sample at an equal amount. The 23 sample buffer with an equal volume was added to the sample, and the final volume was adjusted to 450 ml with rehydration buffer. The proteins were applied to IPG (Immobilised pH gradient) strips (pH 4-7, 24 cm) and focused on an IPGphor (GE Healthcare, UK). Focused IPG strips were equilibrated, and then loaded onto 12% SDS-polyacrylamide gels (SDS-PAGE). The biological triplicates were run on three gels as analytical gels. After SDS-PAGE, three analytical gels were scanned with a Typhoon 9410 scanner (GE Healthcare, UK) and analyzed by DeCyder 5.0 software (GE Healthcare, UK). The differential protein spots (|ratio|>2, p < 0.05) which were altered consistently in all protein spot maps were selected for further identification.
Microarray analysis
The 2 3 10 6 well-conditioned SW480/NC and SW480/shDA-B2IP cells were collected and washed with PBS for three times. Total RNA was isolated with the Trizol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. The cDNA microarray experiment was carried out at Kangcheng Bio-tech laboratory (Shanghai, China) by using RT 2 Profiler TM PCR Array Human Tumor Metastasis (PAHS-028Z).
Immunofluorescence
In brief, cells grown on glass bottom cell culture dishs were fixed in phosphate-buffered saline (PBS) containing 4% paraformaldehyde for 30 min at room temperature, and then treated with 1% triton (AMRESCO, USA) for 10 min at room temperature. Nonspecific binding was blocked by incubation with 1% bovine serum albumin (BSA). Cells were subsequently reacted with hnRNPK or p-hnRNPK antibody (Abcam, USA) for 12 h at 48C, and then stained with second antibodies. After washing with PBS, the cells were visualized under an Olympus CKX41 fluorescence microscope (Olympus, Tokyo, Japan).
Luciferase reporter assay
Cells at 60% confluence in 24-well plate were transfected using lipofectamin 2000. At 48 hr after transfection, luciferase activity was measured using the dual-luciferase reporter assay system (Promega corp, Madison, WI) and normalized to Renilla luciferase gene expression. All the experiments were conducted at least three times and the data are presented as mean SD.
RT-PCR
Real-time PCR was performed by using an Mx3000P realtime PCR system (Stratagene, La Jolla, CA) and SYBR Premix Ex Taq (Takara, Dalian, China) as described previously. 13 Relative quantification of DAB2IP, hnRNPK, MMP2 expressions were evaluated using the Ct method. The fold changes in the relative DAB2IP, hnRNPK, MMP2 gene What's new? DAB2IP is a RasGAP protein that suppresses cancer progression. It is also involved in metastasis of colorectal cancer (CRC). However, the molecular mechanisms are not well understood. In this study, the authors identified several downstream proteins that are regulated by DAB2IP in CRC cells, and revealed how down-regulation of DAB2IP alters transcription in CRC. These results provide a novel mechanism for the role of DAB2IP/hnRNPK/MMP2 axis in the regulation of CRC invasion and metastasis, which may, in turn, offer a potential therapeutic target.
expressions were determined by calculating 2 2DDCt . Primer sequences for qRT-PCR are as follow: DAB2IP-Fwd CTG AGC GGG ATA AGT GGA TGG; DAB2IP-Rev AAA CAT TGT CCG TCT TGA GCTT; hnRNPK-Fwd CAA TGG TGA ATT TGG TAA ACG CC; hnRNPK-Rev GTA GTC TGT ACG GAG AGC CTTA; MMP2-Fwd TGA CTT TCT TGG ATC GGG TCG; MMP2-Rev AAG CAC CAC ATC AGA TGA CTG.
Western blotting analysis
The immunoblot analysis of cell lysates (20- 
Cell invasion assay
The invasion of transfected CRC cells were determined as previously described. 14 
Animal models
For in vivo tumor growth assay, xenograft tumors were generated by subcutaneous injection of 5 3 10 6 cells. Tumors were measured with calipers to estimate volume from Day 5 to Day 25 after injection. For tail vein metastasis assay, a total of 5 3 10 6 cells were injected into the tail veins of nude mice. After 60 days, mice were killed, lung tissues were dissected and subjected to histological examination. Images were taken by Olympus DP72 upright microscope and were outputted by DP2-BSW software.
Immunohistochemical analysis and evaluation
The Medical Ethics Committee of Nanfang hospital approved our experimental protocols. Paraffin-embedded tissue blocks were cut into 2.5 lm sections and transferred to glass slides. The slides were deparaffinized with xylene, rehydrated with ethanol, washed, and subjected to microwave retrieval in a citrate buffer. Sections were then immersed in 3% hydrogen peroxide to block endogenous peroxidase activity and incubated with primary antibodies at 48C for 12 hr followed by incubation with goat anti-mouse or goat anti-rabbit serum for 60 min the next day. The expressions of DAB2IP, hnRNPK and actived-MMP2 were visualized using DAB and counterstained with hematoxylin. For staining of DAB2IP, hnRNPK and actived-MMP2, the scores of positively labelled cell were recored as: 0 (no staining, 0%), 1 (staining range, 1-25%), 2 (staining range, 26-50%), 3 (staining range, 51-75%) or 4 (staining range, 76-100%). Intensity scores were recorded as: 0, no labelling; 1, weak labelling; 2, moderate labelling; or 3, strong labelling. The multiplication of the above two scores representing the results as follows: -(0-1), 1 (2-4), 11 (5-8), 111 (9-12).
Statistical analysis
Quantitative values of all experiments are expressed as the mean 6 SD. Differences among/between sample groups were analyzed by one-way ANOVA or the independent samples t test. Pearson's correlation coefficient was used to measure the degree of the linear relationship between gene mRNA expressions. p < 0.05 was considered to be statistically significant.
Results

hnRNPK and MMP2 are downstream targets of DAB2IP in CRC cells
To explore the molecular mechanism of DAB2IP involved in the progression of CRC, we knocked down DAB2IP in SW480 and HCT116 cell lines and generated stable transfectants (p < 0.01, Supporting Information Fig S1a) , according to endogenous expressions of DAB2IP in seven CRC cell lines. 10 Because the coding domain of DAB2IP gene is as long as 3399 bp and rich in GC contents, we failed to construct the expressing vector. Then we performed 2D DIGE and mass spectrum to screen the differentially expressed proteins between DAB2IP depleting SW480 cells and control cells. As a result, 30 differentially expressed proteins were screened (Fig. 1a , indicated by the numerical labels). From the list of differentially regulated proteins, we focused on hnRNPK (Fig. 1a , indicated by the red arrow in the right panel) as an important downstream target of DAB2IP because it was one of the most upregulated proteins in DAB2IP depleting cells and identified as a potential target of metastasis. 15 But its role and molecular mechanisms in tumor metastasis remains unclear. Upregulation of hnRNPK was further validated in DAB2IP depleting SW480 and HCT116 cells by real-time RT-PCR and Western blotting (p < 0.01, Supporting Information Fig. S1b and 1c ). In addition, we screened differentially expressed genes regulated by DAB2IP knockdown (KD) by using commercial Human Tumor Metastasis cDNA array. We found 58 upregulated genes and 31 down-regulated genes in DAB2IP depleting SW480 cells. Notably, matrix metalloproteinases family (MMPs) showed high expression levels with a 6.92-fold in MMP2, a 4.63-fold in MMP9, a 4.04-fold in MMP3 and a 5.10-fold in MMP13 (Fig. 1b) . Because MMP2 expression was increased most in DAB2IP depleting groups, we chose MMP2 as another downstream target of DAB2IP. Up-regulation of MMP2 was also validated in DAB2IP depleting HCT116 cells by real-Time PCR (p < 0.01, Supporting Information Fig S1d) . The above data support that hnRNPK and MMP2 are downstream targets of DAB2IP in CRC cells.
DAB2IP negatively regulates hnRNPK through MAPK/ERK signaling pathway
Evidence shows that DAB2IP activates MAPK/ERK signaling to promote tumor growth, 16 (Fig. 1f) . Similarly, overexpression of hnRNPK in SW480 and HCT116 cells did not affect the activation of ERK (Fig. 2g) . The above results illustrate that MAPK/ERK signaling pathway is required for DAB2IP-induced hnRNPK expression in CRC cells.
DAB2IP KD activates MAPK/ERK signaling pathway to promote nuclear translocation of hnRNPK in CRC cells
Because hnRNPK expression was regulated by DAB2IP in CRC cells and hnRNPK has been found not only in the nucleus but also in the cytoplasm and mitochondria to regulate chromatin remodeling, transcription, splicing and translation processes, 19 we thus hypothesized whether DAB2IP KD affects the translocation of hnRNPK through MAPK/ ERK signaling pathway in CRC cells. In immunofluorescence experiments, we observed that DAB2IP KD significantly increased p-hnRNPK and total hnRNPK levels in the nucleus, while hnRNPK KD and U0126 treatment in DAB2IP depleting cells showed the opposite effects (Fig. 3a, indicated by the white arrow). Ectopic hnRNPK also promoted the nuclear translocations of p-hnRNPK and total hnRNPK in SW480 and HCT116 cells (Fig. 3a, indicated by the white arrow). We next detected the levels of hnRNPK and phnRNPK in the nucleus and cytoplasm of DAB2IP depleting cells, respectively. The results showed that DAB2IP KD obviously increased the levels of hnRNPK and p-hnRNPK in the nucleus, while U0126 treatment in DAB2IP depleting cells led to decreased hnRNPK and p-hnRNPK expressions (Fig.  3b) . However, the levels of p-hnRNPK and total hnRNPK did not change in the cytoplasm of DAB2IP depleting cells under the stimulation of U0126 (Fig. 3c) . Thus, DAB2IP KD promotes nuclear translocation of hnRNPK by activating MAPK/ERK signaling pathway.
hnRNPK is necessary for DAB2IP induced CRC invasion and metastasis
To validate that down-regulation of DAB2IP mediated CRC progression is through hnRNPK, we performed rescue experiments. Results of invasion assay showed that ectopic hnRNPK promoted cell invasion in SW480 and HCT116 cells (Fig. 4a) . Similar effects on cell invasion were also observed in DAB2IP depleting cells, while both hnRNPK KD and U0126 treatment in DAB2IP depleting cells abolished these promotion effects (Figs. 4b and 4c) . Next, we examined the effect of hnRNPK on DAB2IP-induced tumor growth and metastasis in vivo. Both overexpression of hnRNPK and DAB2IP KD enhanced tumor growth in nude mice compared to control group, while the silence of hnRNPK rescued DAB2IP KD-induced tumor growth (Figs. 4d and 4e) . Moreover, hnRNPK expressing and DAB2IP depleting tumors displayed evidence of local invasion compared to control group. However, hnRNPK and DAB2IP double KD tumors were well encapsulated (Figs. 4d and 4e ). In the experimental metastasis assay, hnRNPK expressing cells and DAB2IP depleting cells produced more lung metastases compared to control cells. However, hnRNPK KD could reverse DAB2IP KD-induced metastasis (Figs. 4f and 4g ). These findings demonstrate that DAB2IP KD promotes invasion, tumor growth and metastasis of CRC cells by regulating hnRNPK.
hnRNPK enhances the transcription activity of MMP2 in CRC cells and requires MMP2 to promote cell invasion
Recent data shows that hnRNPK promotes tumor metastasis by regulating the transcription activities of MMP3 and MMP10. 20 hnRNPK also enhances MMP12 transcription activity to induce invasion in nasopharyngeal carcinoma. 21 So we asked whether hnRNPK enhances the transcription activity of MMP2 in CRC cells. Results of dual lucferase reporter gene assay and real-time RT-PCR showed that hnRNPK significantly enhanced MMP2 transcription activity and also increased the mRNA level of MMP2 in SW480 and HCT116 cells (Figs. 5ac) . Consistently, DAB2IP KD promotes the transcription activity of MMP2 and up-regulated MMP2 in SW480 and HCT116 cells, while hnRNPK KD in DAB2IP depleting cells showed the reverse effects (Figs. 5a, 5d , and 5e). U0126 treatment in DAB2IP depleting cells also downregulated MMP2 (Figs. 5d and 5e ). Western blotting analyses revealed that activated-MMP2 protein level was increased in hnRNPK expressing cells or DABIP2 depleting cells. However, hnRNPK KD and U0126 treatment in DAB2IP depleting cells reduced activated-MMP2 protein level (Figs. 2eg) . To assess whether hnRNPK promoted cell invasion by regulating MMP2, we knocked down MMP2 in hnRNPK expressing SW480 and HCT116 cells (Supporting Information Fig. S1g) .
Results of in vitro invasion assays showed that MMP2 KD significantly inhibited cell invasion potential induced by hnRNPK in CRC cells (Fig. 1f) . The above data make it clear that hnRNPK promotes CRC cell invasion by transcriptionally regulating MMP2.
DAB2IP expression correlates negatively with hnRNPK and MMP2 in CRC tissues
To evaluate the links among DAB2IP, hnRNPK and MMP2 in CRC tissues, we performed IHC to detect the expressions of DAB2IP, hnRNPK and activated-MMP2 in the same 50 paired cases of paraffin embedded CRC tissues. DAB2IP was down-regulated in CRC tissues, consistent with our previous study (Figs 6a, Table 1 ). 10 On the contrary, hnRNPK and activated MMP2 were up-regulated in CRC tissues (p < 0.05, Figs 6b and 6c, Table 1 ). Interestingly, we found that the staining signal of hnRNPK was observed mostly in the cytoplasm of epithelia in adjacent normal mucosa, while in CRC tissues, hnRNPK was detected in the nucleus and cytoplasm of cancer cells (Fig. 6b) , suggesting that nuclear translocation Figs. 6h and 6i) . We also detected the expressions of DAB2IP, hnRNPK and activated MMP2 in SW480 and SW620 cell lines which were derived from the same CRC patient with different metastatic abilities. The result showed that highly metastatic SW620 cells presented down-regulation of DAB2IP and up-regulations of hnRNPK and activated MMP2, while lowly metastatic SW480 cells had the opposite effects (Supporting Information  Fig. S1h) . Collectively, these data show that reduced DAB2IP expression along with increased expression of hnRNPK and MMP2, and the nuclear translocation of hnRNPK are frequent events in human CRC cells. They also verify the importance of DAB2IP/hnRNPK/MMP2 axis in the regulation of CRC invasion and metastasis.
Discussion
In this study, we first identify hnRNPK and MMP2 as important downstream targets of DAB2IP in CRC cells by 2 D-DIGE and metastasis associated cDNA microassay, respectively. In our previous study, we revealed that DAB2IP was a tumor suppressor in the progression of CRC and the importance of snail towards DAB2IP transcription in CRC cells. 10 But, the downstream signaling pathways regulated by DAB2IP in the progression of CRC are still unknown. So we performed 2 D-DIGE and cDNA microassay to screen the differentially expressed genes regulated by DAB2IP in CRC cells, respectively. From the list of differentially expressed genes, we chose hnRNPK and MMP2 because they were the most up-regulated genes in DAB2IP depleting cells. hnRNPK is a member of multifunctional protein family and exerts biological function both inside and outside the nucleus, shares the founctions of regulating translation and processing of RNA with other members of the family. 19 hnRNPK participates in regulating cell cycle, cell apoptosis and tumor metastasis 19 and upregulation of hnRNPK in gastric cancer, liver cancer or lung cancer is related to poor prognosis. [21] [22] [23] MMPs promote tumor growth, metastasis and angiogenesis in the processes of tumor metastasis. 21 MMP2 and MMP9 are the main enzymes, which can degrade type IV collagen, so they play important roles in angiogenesis, invasion and metastasis of tumors. 24, 25 MMP2 can regulate tumor angiogenesis by promoting migration of endothelial cells and activating VEGF. 26 Recent evidence shows that hnRNPK regulates the transcription activity of many MMPs (MMP3, MMP10 and MMP12) to promote tumor progression. 20, 27 So we hypothesized that DAB2IP might regulate MMP2 through hnRNPK, in other words, the DAB2IP/hnRNPK/MMP2 axis might be involved in the progression of CRC.
Second, we show that DAB2IP KD promotes nuclear translocation of hnRNPK through MAPK/ERK signaling pathway and hnRNPK is necessary for DAB2IP-induced CRC invasion and metastasis. In prostate cancer, DAB2IP suppression can activate Ras/ERK signaling pathway and increase expression of p-ERK. 16 In chronic myelogenous leukemia, on one hand, the enhancement of MAPK/ERK activity activates hnRNPK promoter transcriptional activity, and the increased expression of hnRNPK promotes c-myc mRNA translation; on the other hand, the enhancement of MAPK/ ERK activity promotes hnRNPK phosphorylation, which promotes c-myc mRNA translation. 17, 18 So we examined whether DAB2IP KD activated MAPK/ERK signaling pathway in CRC cells. Our results showed that DAB2IP KD increased the levels of p-ERK, hnRNPK and p-hnRNPK, while inhibition of MAPK/ERK signaling reduced the levels of hnRNPK and p-hnRNPK. These results suggest that DAB2IP KD upregulates hnRNPK by activating MAPK/ERK signaling pathway. In nonsmall cell lung cancer, hnRNPK translocates from cytoplasm to nuclei and promotes epithelial mesenchymal transition in tumor cells. 28 Consistent with these findings, our results showed that total hnRNPK and p-hnRNPK were obviously translocated from cytoplasm to nuclei when DAB2IP was knocked down in CRC cells. Particularly, the nuclear translocation of p-hnRNPK was much more obvious than non-phosphorylated hnRNPK. Therefore, it can be assumed that the phosphorylation and nuclear translocation of hnRNPK might be the important drivers for hnRNPKinduced malignant behaviors. Previous study reported that JNK promoted the phosphorylation and nuclear translocation of hnRNPK. 29 Our data showed that interruption of MAPK/ ERK pathway could inhibit the phosphorylation of hnRNPK and its nuclear translocation, indicating the vital role of MAPK/ERK pathway in regulating hnRNPK. To test whether DAB2IP-induced cell invasion and metastasis require hnRNPK, we performed rescue experiments and found that hnRNPK was necessary for DAB2IP-induced CRC cell proliferation, invasion and metastasis in vitro and in vivo. These data support that DAB2IP KD regulates hnRNPK through activating MAPK/ERK signaling to inhibit CRC invasion and metastasis.
Third, we illustrate that phosphorylated hnRNPK significantly enhances the transcription activity of MMP2 in CRC cells and requires MMP2 to promote cell invasion. Recent evidence shows that hnRNPK can combine with nucleus DNA 19, 20, 22 and regulate gene transcription in a form of DNA-protein complex. 22 hnRNPK regulates the transcription activities of MMP3 and MMP10 in the nucleus to affect the proliferation and migration of fibroma cells in vitro. 20 hnRNPK combines with MMP12 promoter and regulates its transcription to promote tumor invasion, in addition to its regulation of MMP2 expression in nasopharyngeal carcinoma. 21 In our study, we found that hnRNPK enhanced the transcription activity of MMP2 and increased the level of activated MMP2 in CRC cells. The possible mechanisms underlying the up-regulation of MMP2 by hnRNPK may include RNA processing or translation process documented in previous studies. [17] [18] [19] The in vitro invasion assay showed that silence of MMP2 obviously suppressed cell invasion induced by hnRNPK in CRC cells. Hence, hnRNPK increases the transcription activity of MMP2 to promote CRC cell invasion. Recent evidence indicates that upregulation of various MMPs impacts the activity of hnRNPK. 20, 21 Thus, we speculate that the interaction between MMPs and hnRNPK might induce a magnification effect on tumor malignant behaviors.
Finally, we provide evidence that the DAB2IP/hnRNPK/ MMP2 axis exists in CRC tissues. In our study, we detected the expressions of DAB2IP, hnRNPK and activated-MMP2 in CRC tissues and found that DAB2IP was down-regulated in CRC tissues while hnRNPK and activated MMP2 were upregulated in CRC tissues. DAB2IP expression correlated negatively with hnRNPK and MMP2 in CRC tissues. DAB2IP has been reported to be low expressed in different kinds of tumors, such as prostate cancer, 7, 16, 30 breast cancer, 31 gastrointestinal tumor, 32 lung cancer, 9 liver cancer, [33] [34] [35] endometrial cancer 36 and bladder cancer. 37 Moreover, DAB2IP is negatively related to the pathological classification and positively related to prognosis. Our preliminary results also showed that DAB2IP could be functioned as an independent prognostic factor in CRC patients. 10 hnRNPK is increased in nasopharyngeal carcinoma, liver cancer and lung cancer and closely related to the prognosis of patients. [21] [22] [23] The expression of p-hnRNPK is positively related to tumor grade and negatively related to CRC prognosis. 38 MMP2 expression is closely related to clinical stage, pathological grading and metastasis of esophageal cancer, gastric cancer, colorectal cancer and liver cancer. [39] [40] [41] Mostly important, we found that nuclear translocation of hnRNPK was obviously observed in CRC cells compared to adjacent normal mucosa epithelia, which further supported that the phosphorylated hnRNPK translocated from cytoplasm to nuclei in DAB2IP KD cells. This evidence clearly validates the role of DAB2IP/hnRNPK/ MMP2 axis in the progression of CRC.
In summary, we reveal the important role of DAB2IP/ hnRNPK/MMP2 signal axis in CRC cell invasion and metastasis. The deficiency of DAB2IP activates MAPK/ERK pathway, which can phosphorylate hnRNPK and promote its accumulation into the nucleus, thereby enhancing the transcription activity of MMP2 and increasing the release of MMP2 within these cells into the surrounding stroma to promote invasion and metastasis of CRC. These findings reveal a new mechanistic of DAB2IP in regulating the progression of CRC and may provide new insights and therapeutic strategies for CRC prevention and treatment.
